Clinical Trials for ReCode Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ReCode Therapeutics

Clinical Trials (4)

NCT06633757
Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
PHASE1Active, not recruiting
12 participants
Started: Oct 22, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor3 locations
NCT06237335
A Phase 1 Study Evaluating Safety and Tolerability of RCT2100 (in CF mRNA) in Healthy Participants and in Participants With CF
PHASE1Recruiting
180 participants
Started: Feb 1, 2024 · Completed: Mar 30, 2026
1 condition1 sponsor23 locations
NCT06172374
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
N/AActive, not recruiting
150 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05685186
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
N/AActive, not recruiting
50 participants
Started: Mar 8, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location